Wider Debate Swirls Over Ruling That Curtailed Berkeley's DNA Program
By Josh Keller,
The Chronicle of Higher Education
| 08. 19. 2010
After months of debate, a ruling by the California Department of Public Health last week put an end to the most controversial part of a student DNA-testing project at the University of California at Berkeley, but now another debate has opened over how academic research will be affected.
Some researchers fear that the health department's position on the Berkeley project could have broader implications for academic research in California, limiting the conditions under which subjects of research studies could learn about potential health issues. Others say those concerns are unfounded.
Berkeley's plan to teach incoming freshmen about personal genetics by allowing them to obtain personal results for three genetic markers sparked a political firestorm. The program put Berkeley in the middle of a heated national debate over the ethics of personal DNA testing, driven by rapid scientific advances and the explosive growth of the personal-testing industry.
State lawmakers unsuccessfully tried to pass a bill to discourage the project, and advocacy groups and some researchers called the program unwise and potentially unethical. Last week, state health regulators said that as long...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...